QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
NASDAQ:MORF

Morphic - MORF Stock Forecast, Price & News

$35.28
+0.73 (+2.11%)
(As of 02/6/2023 12:00 AM ET)
Add
Compare
Today's Range
$33.65
$36.03
50-Day Range
$24.44
$34.55
52-Week Range
$19.23
$47.66
Volume
324,469 shs
Average Volume
261,665 shs
Market Capitalization
$1.36 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$65.29

Morphic MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
85.1% Upside
$65.29 Price Target
Short Interest
Bearish
11.88% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.57
Upright™ Environmental Score
News Sentiment
0.36mentions of Morphic in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$302,992 Sold Last Quarter
Proj. Earnings Growth
Decreasing
From ($1.76) to ($3.66) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.23 out of 5 stars

Medical Sector

311th out of 1,027 stocks

Pharmaceutical Preparations Industry

151st out of 500 stocks

MORF stock logo

About Morphic (NASDAQ:MORF) Stock

Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.

Receive MORF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Morphic and its competitors with MarketBeat's FREE daily newsletter.

MORF Stock News Headlines

"We need batteries. Literally everywhere."
Pretty much every technological megatrend today requires batteries. That includes EVs... 5G... AI... charging stations... and smart energy storage systems. Find out why the U.S. just added graphite to a list of super-critical minerals, calling it "essential for America's National Defense."
Profit From the Commercial Solar Boom?
Solar energy had its best year ever in 2021, with a record 24 gigawatts of power installed. That's enough to power 18 million homes! Analysts expect the global solar farm market to reach $356 billion by 2028. The utility segment of the solar market is expected to grow at the highest annual growth rate in the industry, especially with the many tax incentives now offered.
Schrödinger Hosts Platform Day - StreetInsider.com
See More Headlines
Receive MORF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Morphic and its competitors with MarketBeat's FREE daily newsletter.

MORF Company Calendar

Last Earnings
11/04/2021
Today
2/06/2023
Next Earnings (Estimated)
2/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MORF
Fax
N/A
Employees
101
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$65.29
High Stock Price Forecast
$83.00
Low Stock Price Forecast
$44.00
Forecasted Upside/Downside
+85.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
8 Analysts

Profitability

Net Income
$-95,540,000.00
Pretax Margin
-75.49%

Debt

Sales & Book Value

Annual Sales
$19.79 million
Book Value
$9.11 per share

Miscellaneous

Free Float
28,414,000
Market Cap
$1.36 billion
Optionable
Not Optionable
Beta
1.26

Key Executives

  • Praveen P. Tipirneni
    Chief Executive Officer & Director
  • Bruce N. RogersBruce N. Rogers
    President
  • Marc SchegerinMarc Schegerin
    Chief Operating & Financial Officer
  • Brihad Abhyankar
    Vice President-Clinical Development
  • Blaise Lippa
    Chief Scientific Officer













MORF Stock - Frequently Asked Questions

Should I buy or sell Morphic stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Morphic in the last year. There are currently 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MORF shares.
View MORF analyst ratings
or view top-rated stocks.

What is Morphic's stock price forecast for 2023?

8 Wall Street analysts have issued 12-month target prices for Morphic's shares. Their MORF share price forecasts range from $44.00 to $83.00. On average, they predict the company's stock price to reach $65.29 in the next year. This suggests a possible upside of 85.1% from the stock's current price.
View analysts price targets for MORF
or view top-rated stocks among Wall Street analysts.

How have MORF shares performed in 2023?

Morphic's stock was trading at $26.75 at the start of the year. Since then, MORF stock has increased by 31.9% and is now trading at $35.28.
View the best growth stocks for 2023 here
.

When is Morphic's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our MORF earnings forecast
.

How were Morphic's earnings last quarter?

Morphic Holding, Inc. (NASDAQ:MORF) announced its quarterly earnings data on Thursday, November, 4th. The company reported ($0.69) earnings per share for the quarter, beating the consensus estimate of ($0.73) by $0.04. The firm had revenue of $3.10 million for the quarter, compared to analyst estimates of $5.19 million. Morphic had a negative net margin of 75.53% and a negative trailing twelve-month return on equity of 15.98%. Morphic's revenue for the quarter was down 88.0% compared to the same quarter last year.

What other stocks do shareholders of Morphic own?
When did Morphic IPO?

(MORF) raised $75 million in an IPO on Thursday, June 27th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Jefferies, Cowen, BMO Capital Markets and Wells Fargo Securities served as the underwriters for the IPO.

What is Morphic's stock symbol?

Morphic trades on the NASDAQ under the ticker symbol "MORF."

Who are Morphic's major shareholders?

Morphic's stock is owned by many different retail and institutional investors. Top institutional shareholders include Assenagon Asset Management S.A. (0.29%), SG Americas Securities LLC (0.05%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Alexey Lugovskoy, Amir Nashat, Bruce Rogers, Fund V Gp LP Omega, Fund V LP Omega, Marc Schegerin, Peter Linde, Praveen P Tipirneni, Robert E Farrell Jr, Robert E Farrell, Jr, Timothy A Springer, Timothy A Springer and William Devaul.
View institutional ownership trends
.

How do I buy shares of Morphic?

Shares of MORF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Morphic's stock price today?

One share of MORF stock can currently be purchased for approximately $35.28.

How much money does Morphic make?

Morphic (NASDAQ:MORF) has a market capitalization of $1.36 billion and generates $19.79 million in revenue each year. The company earns $-95,540,000.00 in net income (profit) each year or ($1.52) on an earnings per share basis.

How many employees does Morphic have?

The company employs 101 workers across the globe.

How can I contact Morphic?

Morphic's mailing address is 35 Gatehouse Drive A2, Waltham MA, 02451. The official website for the company is www.morphictx.com. The company can be reached via phone at (781) 996-0955.

This page (NASDAQ:MORF) was last updated on 2/6/2023 by MarketBeat.com Staff